Status Epilepticus: Step-by-Step Therapy and Emergency Management

Status epilepticus is one of the most time-critical emergencies in acute medicine. With a mortality rate of up to 20% in convulsive status epilepticus and significantly higher rates in refractory cases, rapid, structured action is essential. At the same time, distinguishing it from psychogenic non-epileptic seizures presents a diagnostic challenge that is frequently underestimated in the emergency setting. This article examines the current definition, the stepwise pharmacological therapy protocol, and provides you with concrete decision-making tools for both prehospital and in-hospital care.

Definition and Time Concept

The classic definition of status epilepticus as "a continuous seizure lasting more than 5 minutes or two or more seizures without full recovery in between" has proven effective in clinical practice. This is based on the understanding that most epileptic seizures spontaneously terminate within 2–3 minutes. Beyond a seizure duration of 5 minutes, the likelihood of self-limitation drops drastically, and the risk of neuronal damage increases.

The time concept distinguishes two critical thresholds:

• T1 (time to initiate treatment): From 5 minutes of seizure duration – this marks the onset of status epilepticus, and therapy must be initiated.
• T2 (time point of impending long-term damage): From 30 minutes of continuous seizure activity – irreversible neuronal damage becomes imminent, and aggressive therapy escalation is mandatory.

Classification

The following forms are clinically distinguished:

• Convulsive status epilepticus (CSE): Generalized tonic-clonic seizure activity – the most common and most dangerous form in the emergency setting.
• Non-convulsive status epilepticus (NCSE): Subtle or absent motor activity with ongoing electroencephalographic seizure activity. Clinically, this often manifests as impaired consciousness, confusion, or somnolence without visible convulsions.
• Focal status epilepticus: Persistent focal seizure activity, e.g., as epilepsia partialis continua.

NCSE in particular is frequently overlooked in the emergency setting. In any case of unexplained impaired consciousness – especially after a witnessed seizure – NCSE should be considered as a differential diagnosis.

Initial Measures and Basic Management

Before pharmacological therapy begins, basic measures must be carried out in parallel:

• Airway management: Oxygen administration, suction readiness, recovery position if spontaneous breathing is preserved. No bite block – the risk of injury outweighs the supposed benefit.
• Monitoring: SpO₂, ECG, blood pressure measurement, capnography in intubated patients.
• Intravenous access: As quickly as possible – if in doubt, establish intraosseous access.
• Blood glucose measurement: Rule out hypoglycemia as a reversible cause. If BG < 60 mg/dL, immediately administer 40 mL of 40% glucose IV (i.e., 8 g glucose).
• Temperature measurement: Identify fever as a trigger factor and accompanying symptom.
• History: Known epilepsy? Anticonvulsant medication? Last dose taken? Possible triggers (alcohol withdrawal, intoxication, trauma, pregnancy)?

Stepwise Pharmacological Therapy Protocol

The stepwise protocol follows an escalating principle. Each step has a defined time window – if it fails, escalation proceeds without delay.

Step 1: Benzodiazepines (0–5 minutes)

Benzodiazepines are the first-line treatment. The choice of administration route depends on the availability of intravenous access.

With intravenous access:

• Lorazepam 0.1 mg/kg IV (max. 4 mg per single dose), may be repeated once after 5 minutes
• Alternatively: Diazepam 0.15–0.2 mg/kg IV (max. 10 mg per single dose)

Without intravenous access:

• Midazolam 10 mg intranasal, buccal, or intramuscular (in adults > 40 kg)
• Alternatively: Diazepam 10–20 mg rectal (particularly well-established in EMS for children)

Intramuscular administration of midazolam has been shown in studies to be equivalent to intravenous lorazepam when the time advantage of faster administration is taken into account. In the prehospital setting, where intravenous access often cannot be established until after seizure onset, intranasal or intramuscular midazolam is therefore frequently the more pragmatic choice.

Important: The total dose of benzodiazepines should not exceed 0.3 mg/kg lorazepam equivalent to keep the risk of respiratory depression manageable. Intubation readiness must be ensured from Step 1 onward.

Step 2: Established Anticonvulsant Therapy (from 10–20 minutes)

If the seizure does not terminate within 10 minutes after benzodiazepine administration, this is termed benzodiazepine-refractory status epilepticus. Intravenous anticonvulsants are now employed.

The three main options:

Levetiracetam:

• Dosage: 30–60 mg/kg IV (max. 4500 mg), infused over 10–15 minutes
• Advantages: Broad safety profile, virtually no relevant interactions, no enzyme induction, no sedation, no hypotension
• Disadvantages: The evidence for superiority over alternatives is not conclusive
• Particularly suitable for: Unknown medical history, patients on anticoagulation, hepatic insufficiency, elderly patients

Valproic acid:

• Dosage: 20–40 mg/kg IV (max. 3000 mg), infusion rate up to 10 mg/kg/min
• Advantages: Rapid onset of action, strong evidence base in generalized status epilepticus
• Disadvantages: Contraindicated in pregnancy, hepatic insufficiency, mitochondrial disorders, porphyria, and children < 2 years with suspected metabolic disease
• Caution: Thrombocytopenia, pancreatitis, hyperammonemia in pre-existing liver disease

Phenytoin / Fosphenytoin:

• Dosage: 20 mg/kg IV (max. infusion rate: phenytoin 50 mg/min; fosphenytoin 150 mg PE/min)
• Advantages: Long-standing clinical experience, no sedation
• Disadvantages: Cardiovascular side effects (hypotension, arrhythmias – ECG monitoring mandatory), tissue necrosis with extravasation (phenytoin), enzyme induction, complex pharmacokinetics
• Contraindicated in: Second- or third-degree AV block, significant bradycardia

In clinical practice, levetiracetam and valproic acid have replaced phenytoin as second-line therapy in many institutions, primarily due to their more favorable side effect profile. The major randomized trials (ESETT, ConSEPT, EcLiPSE) show comparable efficacy among the three agents, so the choice often depends on contraindications and availability.

Step 3: Refractory Status Epilepticus (from 30–40 minutes)

If Step 2 therapy also fails, a refractory status epilepticus (RSE) is present. This is a situation requiring intensive care unit admission.

Therapy involves initiating continuous intravenous anesthesia:

• Midazolam infusion: Bolus 0.2 mg/kg, then 0.1–0.5 mg/kg/h
• Propofol infusion: Bolus 2 mg/kg, then 1–5 mg/kg/h (Caution: propofol infusion syndrome with prolonged use > 48 h and doses > 5 mg/kg/h)
• Thiopental/Pentobarbital: Bolus 3–5 mg/kg, then 1–5 mg/kg/h (as last resort; pronounced circulatory depression)

Intubation and mechanical ventilation are mandatory at this step. The therapeutic goal is electroencephalographic seizure suppression – ideally a burst-suppression pattern on EEG for 24–48 hours, followed by gradual tapering.

Step 4: Super-Refractory Status Epilepticus

If seizure activity persists despite 24 hours of adequate analgosedation or recurs during tapering attempts, this is termed super-refractory status epilepticus (SRSE). This situation requires interdisciplinary treatment, which may include the following options:

• Ketamine infusion (0.5–5 mg/kg/h) as an NMDA receptor antagonist
• Inhalational anesthetics (isoflurane, desflurane)
• Immunotherapy if autoimmune encephalitis is suspected (methylprednisolone, immunoglobulins, plasmapheresis)
• Hypothermia (32–35 °C)
• Ketogenic diet (described in individual cases even in adults)
• Epilepsy surgery options if a focus can be identified

Etiology Workup: The Search for Reversible Causes

Parallel to seizure treatment, the search for the underlying cause must be pursued. The etiology influences both prognosis and specific therapy.

Common triggers – mnemonic "VITAMIN DE":

• V – Vascular (stroke, cerebral venous sinus thrombosis, intracerebral hemorrhage)
• I – Infection (meningitis, encephalitis, brain abscess)
• T – Trauma (traumatic brain injury)
• A – Autoimmune (autoimmune encephalitis, e.g., anti-NMDA receptor)
• M – Metabolic (hypoglycemia, hyponatremia, hyperammonemia, uremia)
• I – Intoxication / Withdrawal (alcohol withdrawal, medication withdrawal, drug intoxication)
• N – Neoplasia (brain tumors, metastases)
• D – Degenerative / genetic
• E – Epilepsy (breakthrough seizures in known epilepsy, non-adherence)

Recommended baseline diagnostics:

• Blood gas analysis, electrolytes (Na⁺, Ca²⁺, Mg²⁺), blood glucose, lactate
• Antiepileptic drug levels in patients on known therapy
• Toxicology screening
• Non-contrast cranial CT (in first-time presentation or unclear etiology)
• Lumbar puncture (if infection or autoimmune etiology is suspected, after ruling out elevated intracranial pressure)
• EEG (as soon as available – mandatory especially in NCSE)

Differential Diagnosis: Psychogenic Non-Epileptic Seizures (PNES)

One of the most common differential diagnoses in the emergency setting is the psychogenic non-epileptic seizure (PNES, also termed "dissociative seizure"). Up to 20–30% of patients admitted to an intensive care unit with "status epilepticus" actually have PNES. The consequences of misdiagnosis are significant: unnecessary intubation, iatrogenic complications from anticonvulsants, and delayed appropriate therapy.

Clinical Features Suggesting PNES

Feature	Epileptic Seizure	PNES
Eye closure	Usually open	Usually closed (actively squeezed shut)
Eye movements	Tonic upward deviation	Eyes actively averted, lid closure against passive opening
Movement pattern	Synchronous, rhythmic, decreasing frequency	Asynchronous, varying intensity, fluctuating
Duration	Usually < 2 minutes	Often > 5 minutes, sometimes > 30 minutes
Postictal phase	Impaired consciousness, reorientation phase	Rapid reorientation or fluctuating responsiveness
Injuries	Lateral tongue bite, urinary/fecal incontinence possible	Rare
Cyanosis	Common in tonic-clonic seizures	Rare
Response to stimuli	None during the seizure	Possible response to verbal or painful stimuli

Important: No single feature is conclusive. The diagnosis of PNES is a positive diagnosis – it must not be based solely on the exclusion of epilepsy. The gold standard is video-EEG monitoring. However, in the emergency setting this is rarely available, making clinical assessment crucial.

Pragmatic Approach in the Emergency Setting

When in doubt: Treat first, diagnose later. Initial benzodiazepine administration for a presumed status epilepticus is justifiable and generally well tolerated. However, if there is no response to Step 1 therapy and the clinical presentation is atypical, PNES should be actively considered before escalating to Step 2 or proceeding to intubation.

Communication is key: PNES are not "imagined" seizures. They are the expression of a real condition (functional neurological disorder) and require empathetic patient education and referral to specialized neurological/psychiatric facilities.

Special Situations

Eclamptic Seizure

In pregnant women from the 20th week of gestation onward or in the postpartum period, eclamptic seizure is an important differential diagnosis. The first-line treatment is magnesium sulfate (4–6 g IV over 15–20 minutes as a loading dose, then 1–2 g/h as maintenance infusion), not conventional anticonvulsants. Magnesium has been shown to be superior to both benzodiazepines and phenytoin in this setting.

Alcohol Withdrawal Seizures

Alcohol withdrawal seizures are frequently self-limiting but can progress to status epilepticus. Treatment follows the stepwise protocol, with benzodiazepines being particularly effective in this context. Phenytoin is ineffective in pure alcohol withdrawal seizures and should not be used.

Children

Dosages in pediatric patients are strictly weight-based. Buccal midazolam (0.3 mg/kg, max. 10 mg) or rectal diazepam (0.5 mg/kg, max. 10 mg) are well-established first-line measures. The stepwise protocol is escalated analogously to adults, although phenobarbital traditionally plays a larger role in children than in adults.

Common Errors in Emergency Management

• Underdosing of benzodiazepines: A frequent cause of "treatment-refractory" seizures. The full weight-adjusted dose must be administered.
• Remaining on Step 1 for too long: Repeated benzodiazepine doses beyond the recommended total dose instead of escalating to Step 2.
• Failure to search for the underlying cause: The seizure is the symptom, not the diagnosis.
• Missing NCSE: After every convulsive seizure with incomplete recovery, NCSE must be considered.
• Unnecessary intubation for PNES: A critical error that can be avoided through careful clinical observation.
• Phenytoin for alcohol withdrawal seizures: Ineffective and associated with unnecessary side effects.

Practical Training

Status epilepticus requires rapid decision-making under time pressure – from correct benzodiazepine dosing to escalation through the stepwise protocol to differentiating non-epileptic seizures. These processes can be learned in theory, but they can only be truly internalized through practical scenario-based training. In the Emergency Physician Refresher course by Simulation Tirol, you train exactly these time-critical emergency situations in realistic simulations with structured debriefing. For more information, visit simulation.tirol/kurse/notarzt-refresher.